These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10980858)

  • 41. Antiarrhythmic drugs: present and future.
    Sharma S
    J Assoc Physicians India; 2007 Apr; 55 Suppl():43-6. PubMed ID: 18368867
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular charge associated with antiarrhythmic actions in a series of amino-2-cyclohexyl ester derivatives.
    Pugsley MK; Yong SL; Goldin AL; Hayes ES; Walker MJA
    Eur J Pharmacol; 2019 Feb; 844():241-252. PubMed ID: 30571955
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Principles for the classification of anti-arrhythmia agents in cardiac arrhythmias].
    Ravens U
    Z Kardiol; 1992; 81 Suppl 4():119-25. PubMed ID: 1290288
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sodium channel-blocking properties of spiradoline, a kappa receptor agonist, are responsible for its antiarrhythmic action in the rat.
    Pugsley MK; Saint DA; Hayes ES; Kramer D; Walker MJ
    J Cardiovasc Pharmacol; 1998 Dec; 32(6):863-74. PubMed ID: 9869491
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Investigational antiarrhythmic agents: promising drugs in early clinical development.
    Heijman J; Ghezelbash S; Dobrev D
    Expert Opin Investig Drugs; 2017 Aug; 26(8):897-907. PubMed ID: 28691539
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antiarrhythmic drug target choices and screening.
    Sanguinetti MC; Bennett PB
    Circ Res; 2003 Sep; 93(6):491-9. PubMed ID: 14500332
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New directions in the development of antiarrhythmic drugs.
    Miura DS; Rosen MR
    J Clin Pharmacol; 1984 Jul; 24(7):333-41. PubMed ID: 6090508
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cardiac sarcolemmal ion channels and transporters as possible targets for antiarrhythmic and positive inotropic drugs: strategies of the past--perspectives of the future.
    Varro A; Nanasi PP; Acsai K; Virag L; Papp JG
    Curr Pharm Des; 2004; 10(20):2411-27. PubMed ID: 15320753
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical potential of emerging antiarrhythmic agents.
    Capucci A; Aschieri D; Villani GQ; Piepoli MF
    Drugs R D; 1999 Apr; 1(4):279-90. PubMed ID: 10566046
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recent antiarrhythmic drugs.
    Jaillon P; Drici M
    Am J Cardiol; 1989 Dec; 64(20):65J-69J. PubMed ID: 2688391
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Update on new antiarrhythmic drugs.
    Morton PG
    Crit Care Nurs Clin North Am; 1994 Mar; 6(1):69-83. PubMed ID: 8192885
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Targeting cardiac potassium channels for state-of-the-art drug discovery.
    Walsh KB
    Expert Opin Drug Discov; 2015 Feb; 10(2):157-69. PubMed ID: 25400064
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Sicilian Gambit and antiarrhythmic drug development.
    Colatsky TJ
    Cardiovasc Res; 1992 Jun; 26(6):562-5. PubMed ID: 1333361
    [No Abstract]   [Full Text] [Related]  

  • 54. Antiarrhythmic drugs: new agents and evolving concepts.
    Nemec J; Shen WK
    Expert Opin Investig Drugs; 2003 Mar; 12(3):435-53. PubMed ID: 12605566
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antiarrhythmics--from cell to clinic: past, present, and future.
    Hancox JC; Patel KC; Jones JV
    Heart; 2000 Jul; 84(1):14-24. PubMed ID: 10862579
    [No Abstract]   [Full Text] [Related]  

  • 56. Newer antiarrhythmic drugs.
    Michelson EL; Dreifus LS
    Med Clin North Am; 1988 Mar; 72(2):275-319. PubMed ID: 3279283
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Arctigenin, a potential anti-arrhythmic agent, inhibits aconitine-induced arrhythmia by regulating multi-ion channels.
    Zhao Z; Yin Y; Wu H; Jiang M; Lou J; Bai G; Luo G
    Cell Physiol Biochem; 2013; 32(5):1342-53. PubMed ID: 24280730
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preventing unfolded protein response-induced ion channel dysregulation to treat arrhythmias.
    Liu M; Kang GJ; Dudley SC
    Trends Mol Med; 2022 Jun; 28(6):443-451. PubMed ID: 35414478
    [TBL] [Abstract][Full Text] [Related]  

  • 59. New advances in class III antiarrhythmic drug therapy.
    Sager PT
    Curr Opin Cardiol; 1999 Jan; 14(1):15-23. PubMed ID: 9932203
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Arrhythmia models for drug research: classification of antiarrhythmic drugs.
    Hashimoto K
    J Pharmacol Sci; 2007 Apr; 103(4):333-46. PubMed ID: 17409630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.